Zobrazeno 1 - 10
of 211
pro vyhledávání: '"Platinum resistant ovarian cancer"'
Publikováno v:
Journal of Ovarian Research, Vol 17, Iss 1, Pp 1-14 (2024)
Abstract Platinum is a key component of ovarian cancer systemic therapy. However, most patients will eventually face a recurrence, leading to chemotherapy resistance, especially against platinum. For individuals with platinum-resistant ovarian cancer
Externí odkaz:
https://doaj.org/article/541b2e7e85ac45dea6c42a57fd0bb864
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 63, Iss 4, Pp 471-478 (2024)
Platinum-resistant ovarian cancer (PROC) refers to disease progression within 6 months after the completion of platinum-based chemotherapy. Historically, treatment options for PROC were limited with a poor prognosis and non-platinum single agent plus
Externí odkaz:
https://doaj.org/article/e4640a81c7a1447bb6977ae1266e6521
Autor:
Marta Kluz-Barłowska, Tomasz Kluz, Wiesław Paja, Krzysztof Pancerz, Monika Łączyńska-Madera, Paulina Miziak, Jozef Cebulski, Joanna Depciuch
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Platinum-resistant phenomena in ovarian cancer is very dangerous for women suffering from this disease, because reduces the chances of complete recovery. Unfortunately, until now there are no methods to verify whether a woman with ovarian ca
Externí odkaz:
https://doaj.org/article/6737e83493164db4a150e2a3a11b54fa
Publikováno v:
Gynecologic Oncology Reports, Vol 54, Iss , Pp 101452- (2024)
Introduction: Patients with platinum resistant epithelial ovarian cancer have limited treatment options which are further limited by hypersensitivity reactions to first line medications such as paclitaxel. Paclitaxel is a taxane that inhibits microtu
Externí odkaz:
https://doaj.org/article/69e75ee5b6454b8c9be7f0d1e1e7812b
Autor:
Yinu Wang, Andrea E. Calvert, Horacio Cardenas, Jonathon S. Rink, Dominik Nahotko, Wenan Qiang, C. Estelle Ndukwe, Fukai Chen, Russell Keathley, Yaqi Zhang, Ji‐Xin Cheng, C. Shad Thaxton, Daniela Matei
Publikováno v:
Advanced Science, Vol 11, Iss 13, Pp n/a-n/a (2024)
Abstract Platinum (Pt)‐based chemotherapy is the main treatment for ovarian cancer (OC); however, most patients develop Pt resistance (Pt‐R). This work shows that Pt‐R OC cells increase intracellular cholesterol through uptake via the HDL recep
Externí odkaz:
https://doaj.org/article/c74208f5f91d408dacb341f964db8aef
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Introduction To evaluate the efficacy of cytoreductive surgery versus chemotherapy for the treatment of limited regional, platinum-resistant ovarian cancer (PROC). Materials and methods The clinical records of all patients with PROC treated
Externí odkaz:
https://doaj.org/article/afe9c756ed0242c8a72b31706195cbc6
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundPatients with platinum-resistant recurrent high grade serous ovarian carcinoma have poor outcomes and limited treatment options.Case presentationWe present a case of a 48-year-old woman with platinum-resistant high grade serous ovarian carc
Externí odkaz:
https://doaj.org/article/f11e3fa3b6a247dcb107112f535477c8
Autor:
Yi Qin, Shangke Huang, Junli Tang, Yu Fan, Xiangyu Deng, Ping Guan, Zhenhua Zhang, Qinglian Wen, Dan Li
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
BackgroundTreatment for platinum-resistant ovarian cancer is challenging. Currently, platinum-resistant ovarian cancer is typically treated with non-platinum single-agent chemotherapy ± bevacizumab, but the prognosis is often extremely poor. In the
Externí odkaz:
https://doaj.org/article/b27c62a44a694861bbb5d5145327b557
Autor:
Ramez N. Eskander, Kathleen N. Moore, Bradley J. Monk, Thomas J. Herzog, Christina M. Annunziata, David M. O’Malley, Robert L. Coleman
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
The definition of “platinum-resistant ovarian cancer” has evolved; it now also reflects cancers for which platinum treatment is no longer an option. Standard of care for platinum-resistant ovarian cancer is single-agent, non-platinum chemotherapy
Externí odkaz:
https://doaj.org/article/358e10443d3f428898b57cc9d3f7a136
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.